Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Bayer reaches $6.9 million settlement with New York over Roundup safety claims

Published 15/06/2023, 16:17
© Reuters. FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay/File Photo

By Jonathan Stempel

NEW YORK (Reuters) -Bayer AG agreed on Thursday to pay $6.9 million to settle claims by New York Attorney General Letitia James that it misled consumers by advertising Roundup weedkiller, which has been linked to cancer, as environmentally safe.

The settlement resolves accusations that Bayer (ETR:BAYGN) and its Monsanto (NYSE:MON) unit failed to substantiate their repeated claims about Roundup products containing the active ingredient glyphosate.

These included that Roundup "won't harm anything but weeds" and "do not pose a threat to the health of animal wildlife," as well as suggestions in since-removed YouTube videos that Roundup was safer than detergent and soap.

James said the claims violated state laws against false and misleading advertising, and breached Monsanto's 1996 settlement with New York over its advertising of Roundup at the time.

"Pesticides can cause serious harm to the health of our environment, and pose a deadly threat to wildlife," and companies that make them must be "honest" with consumers about the dangers, James said in a statement.

Thursday's settlement requires Bayer to stop advertising glyphosate-based Roundup as a safe and non-toxic product.

The $6.9 million will be spent on reducing the impact of pesticides on pollinators and aquatic species.

Bayer did not admit or deny wrongdoing.

In a statement, the German company said it was pleased to settle. It also noted that the attorney general probe, which began in 2020, drew no scientific conclusions about Roundup.

Bayer has faced extensive litigation over whether Roundup causes cancer since it spent $63 billion to buy Monsanto in 2018.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

It agreed to settle much of that litigation for $10.9 billion in 2020. As of February, about 109,000 of the 154,000 claims Bayer has faced had been settled or deemed ineligible.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.